Beyond chronic kidney disease: the diagnosis of Renal Disease in the Elderly as an unmet need. A position paper endorsed by Italian Society of Nephrology (SIN) and Italian Society of Geriatrics and Gerontology (SIGG)

被引:0
作者
Filippo Aucella
Andrea Corsonello
Dario Leosco
Giuliano Brunori
Loreto Gesualdo
Raffaele Antonelli-Incalzi
机构
[1] Fondazione IRCCS “Casa Sollievo della Sofferenza”,Department of Nephrology and Dialysis
[2] IRCCS INRCA,Unit of Geriatric Pharmacoepidemiology
[3] Federico II University of Naples,Division of Geriatrics, Department of Translational Medical Sciences
[4] Santa Chiara Hospital,Department of Nephrology and Dialysis
[5] Azienda Provinciale Servizi Sanitari,Division of Nephrology
[6] University “Aldo Moro”,Unit of Geriatrics
[7] Campus Bio-Medico University,undefined
来源
Journal of Nephrology | 2019年 / 32卷
关键词
Chronic kidney disease; Elderly; Geriatrics; Renal ageing; Renal disease;
D O I
暂无
中图分类号
学科分类号
摘要
The dramatic increase in prevalence of chronic kidney disease (CKD) with ageing makes the recognition and correct referral of these patients of paramount relevance in order to implement interventions preventing or delaying the development of CKD complications and end-stage renal disease. Nevertheless, several issues make the diagnosis of CKD in the elderly cumbersome. Among these are age related changes in structures and functions of the kidney, which may be difficult to distinguish from CKD, and multimorbidity. Thus, symptoms, clinical findings and laboratory abnormalities should be considered as potential clues to suspect CKD and to suggest screening. Comprehensive geriatric assessment is essential to define the clinical impact of CKD on functional status and to plan treatment. Correct patient referral is very important: patients with stage 4–5 CKD, as well as those with worsening proteinuria or progressive nephropathy (i.e. eGFR reduction > 5 ml/year) should be referred to nephrologist. Renal biopsy not unfrequently may be the key diagnostic exam and should not be denied simply on the basis of age. Indeed, identifying the cause(s) of CKD is highly desirable to perform a targeted therapy against the pathogenetic mechanisms of CKD, which complement and may outperform in efficacy the general measures for CKD.
引用
收藏
页码:165 / 176
页数:11
相关论文
共 286 条
[1]  
Collins AJ(2012)‘United States Renal Data System 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States Am J Kidney Dis 59 A7-1252
[2]  
Foley RN(2017)Chronic kidney disease Lancet 389 1238-420
[3]  
Chavers B(2017)Renal aging: causes and consequences J Am Soc Nephrol 28 407-6479
[4]  
Webster AC(1997)Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy Proc Natl Acad Sci USA 94 6474-331
[5]  
Nagler EV(2003)Advanced glycation end products in uremia Adv Ren Replace Ther 10 321-1616
[6]  
Morton RL(2011)Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1 Diabetes Care 34 1610-121
[7]  
Masson P(2014)Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling Cell Signal 26 110-80
[8]  
O’Sullivan ED(2014)The aging kidney revisited: a systematic review Ageing Res Rev 14 65-1788
[9]  
Hughes J(2017)Chronic kidney disease: a likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease Geriatr Gerontol Int 17 1770-277
[10]  
Ferenbach DA(2012)The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli Kidney Int 82 270-285